Evidence map›Paper›PMID 26083323›Full record

ArticleAutophagy2015

ATG16L1 phosphorylation is oppositely regulated by CSNK2/casein kinase 2 and PPP1/protein phosphatase 1 which determines the fate of cardiomyocytes during hypoxia/reoxygenation.

Huiwen Song, Jun Pu, Lin Wang, Lihua Wu, Jianmin Xiao, Qigong Liu, Jun Chen, Min Zhang, Yang Liu, Mingke Ni and 18 more

Open access · bronzeAbstract read
In one paragraph

Article in Autophagy, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 2 pooled it
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 2 syntheses or guidelines pooled it, 65 citations in OpenAlex.

  1. Guideline
  2. Guideline
  3. Article
  4. Article
  5. METTL3: a multifunctional regulator in diseases.Molecular and cellular biochemistry · 2025
    Review
  6. Review
  7. ZDHHC7-mediatedAutophagy · 2024
    Article
  8. Article
  9. Review
  10. Review
  11. mPeerJ · 2023
    Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Epitranscriptomics of cardiovascular diseases (Review).International journal of molecular medicine · 2022
    Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors at 16 institutions in 3 countries.

Huiwen Songa Department of Cardiology ; Affiliated Baoan Hospital of Southern Medical University ; Shenzhen , China.
Jun Pu
Lin Wang
Lihua Wu
Jianmin Xiao
Qigong Liu
Jun Chen
Min Zhang
Yang Liu
Mingke Ni
Jinggang Mo
Yunliang Zheng
Deli Wan
XiongJiu Cai
Yaping Cao
Weiyi Xiao
Lei Ye
Enyuan Tu
Zhihai Lin
Jianxin Wen
Xiaoling Lu
Jian He
Yi Peng
Jing Su
Heng Zhang
Yongxiang Zhao
Meihua Lin
Zhiyong Zhang
Southern Medical University Shenzhen Hospital · CNTarget (United States) · USTongji Hospital · CNFirst Affiliated Hospital Zhejiang University · CNGuangxi Medical University · CNChina Three Gorges University · CNDongguan People’s Hospital · CNGuangdong General Hospital · CNHainan Branch of People's Liberation Army General Hospital · CNHuazhong University of Science and Technology · CNJinan University · CNSun Yat-sen University · CNTaizhou Central Hospital · CNUnion Hospital · CNZhejiang University · CNZhongshan Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent studies have shown that the phosphorylation and dephosphorylation of ULK1 and ATG13 are related to autophagy activity. Although ATG16L1 is absolutely required for autophagy induction by affecting the formation of autophagosomes, the post-translational modification of ATG16L1 remains elusive. Here, we explored the regulatory mechanism and role of ATG16L1 phosphorylation for autophagy induction in cardiomyocytes. We showed that ATG16L1 was a phosphoprotein, because phosphorylation of ATG16L1 was detected in rat cardiomyocytes during hypoxia/reoxygenation (H/R). We not only demonstrated that CSNK2 (casein kinase 2) phosphorylated ATG16L1, but also identified the highly conserved Ser139 as the critical phosphorylation residue for CSNK2. We further established that ATG16L1 associated with the ATG12-ATG5 complex in a Ser139 phosphorylation-dependent manner. In agreement with this finding, CSNK2 inhibitor disrupted the ATG12-ATG5-ATG16L1 complex. Importantly, phosphorylation of ATG16L1 on Ser139 was responsible for H/R-induced autophagy in cardiomyocytes, which protects cardiomyocytes from apoptosis. Conversely, we determined that wild-type PPP1 (protein phosphatase 1), but not the inactive mutant, associated with ATG16L1 and antagonized CSNK2-mediated phosphorylation of ATG16L1. Interestingly, one RVxF consensus site for PPP1 binding in the C-terminal tail of ATG16L1 was identified; mutation of this site disrupted its association with ATG16L1. Notably, CSNK2 also associated with PPP1, but ATG16L1 depletion impaired the interaction between CSNK2 and PPP1. Collectively, these data identify ATG16L1 as a bona fide physiological CSNK2 and PPP1 substrate, which reveals a novel molecular link from CSNK2 to activation of the autophagy-specific ATG12-ATG5-ATG16L1 complex and autophagy induction.

Indexed as

Gene Expression RegulationAmino Acid SequenceAnimalsApoptosisAutophagyAutophagy-Related Protein 5Autophagy-Related ProteinsBinding SitesCarrier ProteinsCasein Kinase IICell HypoxiaCell LineageHEK293 CellsHumansMiceMice, Inbred C57BLATG16L1 protein, humanATG5 protein, humanAutophagy-Related Protein 5Autophagy-Related ProteinsCarrier ProteinsCasein Kinase IICSNK2A1 protein, humanMicrotubule-Associated ProteinsOxygenPPP1CA protein, humanProtein Phosphatase 1Recombinant ProteinsSerineATG16L1autophagycardiomyocytecasein kinase 2protein phosphatase 1

Identifiers

PMID26083323
PMCPMC4590681
OpenAlexW1613089073

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.